Description

The end of Chevron deference and President Trump's reelection mean federal agencies like the Centers for Medicare & Medicaid Services, Health Resources and Services Administration, and the Food and Drug Administration will operate under fundamentally different rules than in the past. This presentation explained the changes and identified what organizations need to know.

Learning objectives for this session included the following:

• Provided key background on the Chevron doctrine, which required courts to defer to agencies' interpretations of statutes, and the Supreme Court's overturning of it in Loper Bright
• Identified important changes resulting from Chevron's end and the election of President Trump, including more cautious rulemaking, more frequent challenges to agency actions, and more restrictions on subregulatory guidance
• Identified risks and opportunities for healthcare companies that are subject to agencies' rules, actions, and guidance

On January 23-24, PYA and Foley & Lardner LLP presented the seventh annual Let's Talk Compliance virtual conference. The event was moderated by Foley Health Care Partner Jana Kolarik and PYA Principal Angie Caldwell. Panelists included attorneys from Foley's Health Care & Life Sciences Sector as well as PYA's healthcare consulting, compliance, and cybersecurity experts. Each day featured two sessions that covered relevant and trending topics in healthcare and life sciences compliance.